Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
65.67
-0.87 (-1.31%)
Dec 5, 2025, 4:00 PM EST - Market closed
Cytokinetics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 8,029 | 5,551 | 8,186 | 4,336 | 3,823 | 1,471 | |
| Market Cap Growth | 33.17% | -32.19% | 88.80% | 13.41% | 159.96% | 134.31% | |
| Enterprise Value | 8,417 | 5,448 | 8,396 | 4,210 | 3,612 | 1,201 | |
| Last Close Price | 65.67 | 47.04 | 83.49 | 45.82 | 45.58 | 20.78 | |
| PS Ratio | 89.62 | 300.50 | 1087.18 | 45.84 | 54.29 | 26.35 | |
| PB Ratio | - | -41.01 | -21.19 | -40.18 | 15.68 | 12.97 | |
| P/TBV Ratio | - | - | - | - | 15.68 | 12.97 | |
| P/OCF Ratio | - | - | - | - | - | 164.46 | |
| EV/Sales Ratio | 96.51 | 294.90 | 1115.03 | 44.50 | 51.29 | 21.51 | |
| Debt / Equity Ratio | -2.59 | -6.82 | -1.96 | -6.95 | 1.11 | 1.23 | |
| Asset Turnover | 0.06 | 0.02 | 0.01 | 0.10 | 0.10 | 0.14 | |
| Quick Ratio | 6.78 | 6.08 | 6.00 | 9.25 | 7.35 | 15.10 | |
| Current Ratio | 6.88 | 6.17 | 6.12 | 9.40 | 7.45 | 15.20 | |
| Return on Equity (ROE) | - | - | - | -572.15% | -120.54% | -248.50% | |
| Return on Assets (ROA) | -24.93% | -30.11% | -33.73% | -21.83% | -16.94% | -14.26% | |
| Return on Capital (ROIC) | -41.55% | -57.92% | -61.30% | -35.05% | -30.40% | -31.11% | |
| Return on Capital Employed (ROCE) | -44.30% | -43.90% | -68.80% | -34.90% | -24.20% | -18.70% | |
| Earnings Yield | -9.37% | -10.62% | -6.43% | -8.97% | -5.63% | -8.65% | |
| FCF Yield | -5.65% | -7.20% | -5.08% | -7.17% | -5.01% | -0.14% | |
| Buyback Yield / Dilution | -11.00% | -16.01% | -7.46% | -16.83% | -19.16% | -12.07% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.